Archives

by in
Entry Author Date Location
WI-based FluGen Raises $3.4M For Universal Flu Vaccine Phase I Trial 06/02/14 Wisconsin
Myriad RBM Test Helping to Mine Secrets of Normal Immune System 04/16/14 Texas
Lucigen Takes On Diagnostic Giants With On-the-Spot Pathogen Tests 01/30/14 Wisconsin
Theraclone Merges With PharmAthene, Plans to Stay in Seattle 08/01/13 Seattle
East Coast Life Sciences Roundup: GSK, Protein Sciences, IMS Health 03/15/13 Boston
IDRI, Medicago To Test Self-Injectable Pandemic Flu Vaccine 08/16/12 Seattle
Theraclone Takes 2nd Antibody into the Clinic Against Common Virus 06/14/12 Seattle
Theraclone Passes First Clinical Test with Flu-Fighting Antibody 05/15/12 Seattle
Theraclone Names Cliff Stocks, Vet of Icos & Calistoga, as New CEO 12/06/11 Seattle
UW Scores $40M for Biofuels, Cocrystal’s Fight Against HepC, The Women’s Biotech Network, & More Seattle-Area Life Sciences News 09/29/11 Seattle
The Immunex Impact, Calypso Gets Acquired, Women in Bio’s Kickoff, & More in Seattle-Area Life Sciences News 09/22/11 Seattle
Theraclone Enters Clinical World, With Flu Antibody That Might Be Handy in Pandemic 09/21/11 Seattle
NYC’s Vivaldi, Allied With Harvard and San Francisco VC Firm, Forge a New Way to Fight the Flu 04/28/11 New York
VBI Progressing with Vaccines That Don’t Require Refrigeration 03/24/11 Boston
Gates Foundation Makes First Equity Investment in a Biotech Startup, Liquidia Technologies 03/08/11 Seattle
Theraclone Strikes $632M Deal With Pfizer to Discover Antibodies for Cancer, Infections 01/18/11 Seattle
NanoBio Passes First Key Clinical Trial With Nasal Flu Vaccine, Scopes Other Opportunities 09/16/10 Detroit
Seattle Genetics’ Dark Horse Fails, The Future of Zymo’s Landmark, PATH Nabs Flu Vaccine Contract, & More Seattle-Area Life Sciences 09/16/10 Seattle
PATH Snaps Up $5M Contract to Make Flu Vaccines For Stockpiling, Hot Conditions 09/15/10 Seattle
Former Solvay Pharma Chief Takes Lead Role at Startup Selecta Biosciences 08/16/10 Boston
Immune Design Follows Corixa Playbook, Sees Data, Deals on the Horizon in Year Three 07/27/10 Seattle
Visterra, Previously Parasol, Expands with $6M 07/12/10 Boston
Theraclone Sciences CEO David Fanning Dies Suddenly 06/14/10 Seattle
ZymoGenetics Gets Upstaged, Calistoga Cancer Drug Matures, Cramer Replaces Kraemer, & More Seattle-Area Life Sciences News 06/11/10 Seattle
AVI Biopharma Gets $18M Flu Contract 06/07/10 Seattle
FDA OK’s IMDx H1N1 Test 03/24/10 Boston
AVI Biopharma Eagerly Awaits Data on Muscular Dystrophy Drug 02/01/10 Seattle
The Top Five Biotech Innovations of the 2000s 12/15/09 Seattle
Quidel OKs $25M in Share Buybacks 12/08/09 San Diego
Seattle’s Kineta Rakes in Half of $13M Federal Contract to UW For Vaccine Boosters 11/10/09 Seattle
Page 1 of 3 next page »